Recently, the "China (Guangdong)-U.S. (New York) Economic and Trade Cooperation Conference" was held in New York. The Guangdong delegation, consisting of 85 Chinese enterprises, and representatives from about 200 U.S. companies, participated in the conference.
A total of 28 cooperation projects – covering real estate, environmental protection, education, health care, telecommunications, biotechnology and other areas – were signed by the two sides, with the contracted amount of money reaching US $ 4.14 billion. It's worth mentioning that the Hengqin Financial Investment Co., Ltd. joined a bioscience fund, which was signed by GF Xinde Investment Management and the leading American life-science investment institution Bay City Capital.
It is understood that with the help of the bioscience fund, Hengqin can introduce world-class enterprises and technology to China. Also, Chinese enterprises can obtain competitive products and technologies from the world and get rewards through a "cross-border mergers and acquisitions + technology licensing" model.
By the end of 2015, Guangdong had set up over 555 non-financial enterprises in the United States, with the amount of agreed investment reaching US $ 3.7 billion and the actual investment coming to over US $ 2.1 billion. In 2015, Guangdong's import and export to the US ran up to US $ 128.4 billion, accounting for 23 percent of China's total.